IRIS
INTINI, Francesco Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.012
AS - Asia 1.790
EU - Europa 1.149
SA - Sud America 429
AF - Africa 57
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.970
SG - Singapore 755
CN - Cina 575
BR - Brasile 373
SE - Svezia 334
HK - Hong Kong 245
RU - Federazione Russa 151
UA - Ucraina 149
IT - Italia 134
DE - Germania 117
FI - Finlandia 107
VN - Vietnam 73
GB - Regno Unito 61
IN - India 45
CA - Canada 22
CI - Costa d'Avorio 18
FR - Francia 18
BE - Belgio 16
ZA - Sudafrica 16
AR - Argentina 14
BD - Bangladesh 14
IE - Irlanda 14
MX - Messico 13
IQ - Iraq 12
PL - Polonia 12
TR - Turchia 11
IR - Iran 10
EC - Ecuador 9
MA - Marocco 9
ID - Indonesia 8
CZ - Repubblica Ceca 7
PY - Paraguay 7
SA - Arabia Saudita 7
VE - Venezuela 7
AT - Austria 6
CO - Colombia 6
ES - Italia 6
JP - Giappone 6
CL - Cile 5
JO - Giordania 5
KE - Kenya 5
PK - Pakistan 5
NL - Olanda 4
TN - Tunisia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
PE - Perù 2
PT - Portogallo 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
Totale 8.440
Salva come PNG Salva come JPEG
Città #
Fairfield 696
Woodbridge 460
Chandler 440
Ashburn 399
Singapore 364
Jacksonville 314
Houston 289
Seattle 283
Nyköping 276
Hong Kong 243
Cambridge 236
Wilmington 210
Ann Arbor 156
Beijing 130
Nanjing 128
New York 103
Lawrence 92
Roxbury 92
Boardman 87
Princeton 70
Des Moines 62
Bari 59
Los Angeles 51
Nanchang 51
Brooklyn 39
Inglewood 39
Ho Chi Minh City 34
São Paulo 33
Dallas 30
San Diego 28
Helsinki 27
Jiaxing 26
Dearborn 25
Santa Clara 25
Buffalo 24
Shenyang 24
Pune 20
Abidjan 18
Hebei 18
Rio de Janeiro 18
Munich 17
San Mateo 17
Brussels 16
Tianjin 16
Changsha 15
Hanoi 14
Kunming 14
Jinan 12
Johannesburg 12
Leawood 12
Dublin 11
Molfetta 11
Chicago 10
Guangzhou 10
San Francisco 10
Warsaw 10
Ardabil 9
Curitiba 9
Noicattaro 9
San Jose 9
Belo Horizonte 8
Corridonia 8
Denver 8
Monmouth Junction 8
London 7
Mumbai 7
Shanghai 7
Stockholm 7
Washington 7
Birmingham 6
Brno 6
Jakarta 6
Lanzhou 6
Lauterbourg 6
Toronto 6
Amman 5
Augusta 5
Baghdad 5
Boston 5
Brasília 5
Fortaleza 5
Montreal 5
Moscow 5
Nairobi 5
Paris 5
Phoenix 5
Taizhou 5
Tokyo 5
Atlanta 4
Campo Grande 4
Cuiabá 4
Marseille 4
Montevideo 4
Norwalk 4
Nuremberg 4
Quito 4
Riyadh 4
Wuhan 4
Zhengzhou 4
Adelfia 3
Totale 6.177
Salva come PNG Salva come JPEG
Nome #
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 197
Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects 170
Novel Antitumor Cisplatin and Transplatin Derivatives Containing 1‑Methyl-7-Azaindole: Synthesis, Characterization, and Cellular Responses 164
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 144
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 138
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 135
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 123
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 122
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 120
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 119
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 119
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 117
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 117
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 117
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 117
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 114
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 114
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 114
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 114
Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of Guanine nucleotides in Platinum complexes with a single guanine ligand 114
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 113
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 113
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 109
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 107
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 107
Bis[iodo(N,N,N′,N'',N''-pentamethyldiethyl-enetriamine- kappa N-3)platinum(II)] di-μ-iodobis[diiodoplatinate(II)] 105
null 104
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 103
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 103
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 103
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 102
Solution Behavior of Amidine Complexes: An Unexpected cis/trans Isomerization and Formation of Di- and Trinuclear Platinum(III) and Platinum(II) Species 100
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 100
Synthesis and X-ray crystal structure of a trans-dichloro(1-cyano-2,2-dimethylpropane)(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 94
Solvolysis of Platinum Complexes with Substituted Ethylenediamines in Dimethylsulfoxide 93
New steric hindrance approach employing the hybrid ligand 2-aminomethylpiperidine for diminishing dynamic motion problems of platinum anticancer drug adducts containing guanine derivatives 92
Factors Influencing the Configuration and Conformation of Diamine Chelate Rings in Platinum(II) Compounds: 2,4- Bis(methylamino)pentane Complexes 92
Effects of six-membered-ring conformation on the rotamer distribution and rate of atropisomerization in platinum(II)-guanine compounds: 2,4-bis(methylamino)pentane complexes 89
null 89
Structural characterization of the “lantern-shaped” platinum(III) complex [Pt2Cl2{N(H)C(But)O}4] 88
null 88
Energetics, conformation, and recognition of DNA duplexes modified by methylated analogues of [PtCl(dien)]+ 87
Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes 85
Isolation, Characterization, and Kinetics of Formation of the cis and trans Isomers of Bis(acetonitrile)dichloroplatinum(II) 85
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 83
Synthesis and spectroscopic and structural characterization of different configurations of the tridentate amine ligand N,N’,N’’-trimethyldiethylenetriamine coordinated to platinum 82
trans-Chloridobis[(Z)-1-imino-1-methoxyethane-N](triphenylphosphane-P)platinum(II) chloride monohydrate 82
Cisplatin and zoledronic acid: two drugs combined in a Pt(II) complex with potential antitumor activity towards bone tumors and metastases 80
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 80
null 80
Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's 79
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 77
Platinum(II) complexes with the purine derivatives Penciclovir and Famciclovir; monoadducts with potential antitumor and antiviral activity 76
IRREVERSIBLE ADDITION OF CARBON NUCLEOPHILES TO ETHYLENE IN CATIONIC PLATINUM(II) COMPLEXES 76
Complessi antitumorali di platino a geometria trans 76
Retro-Models of Pt Anticancer Drug DNA Adducts: Chirality-Controlling Chelate (CCC) Ligand Restriction of Guanine Dynamic Motion in (2,2'-Bipiperidine)PtG2 Complexes (G = Guanine Derivative) 75
Synthesis and X-Ray Structural Characterization of the First Unbridged Diplatinum(III) Compound: Bis[bis(1-imino-1-hydroxy-2,2-dimethyl-propane)-trichloroplatinum(III)] 75
A trans-platinum complex showing higher antitumor activity than the cis congeners 74
Sinthesis and stereochemical characterisation of platinum(II) complexes with the antiviral agents penciclovir and famciclovir 73
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 73
Synthesis and Crystal Structure of a Trans-Diaquabis(amidato) Complex of Platinum(II) 72
Stereochemical Investigations of Cationic Olefin Complexes of Platinum(II) Containing Chiral Diamines: a Sequence of Four Asymmetric Centres (N, C, C and N) in the chelate ring 72
Cyclodextrin polymers as carriers for the platinum-based anticancer agent LA-12 72
X-ray Structural Characterization of the Bis-Guanine Derivative of a Cisplatin Analogue Having Just One Proton on Each Coordinated Nitrogen and a Head-to-Head Conformation: [Pt{(±)-N,N'-dimethylbutane-2,3-diamine}(9-ethyl-guanine)2]dinitrate 71
NUCLEOPHILIC-ATTACK OF METHANOL ON BIS(BENZONITRILE)DICHLOROPLATINUM - FORMATION OF MONO-IMIDO AND BIS-IMIDO ESTER DERIVATIVES 71
Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration 70
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 70
Biochemical aspects of antitumor effects of a new platinum(IV) drug 70
Retro-modeling in Pt anticancer drug chemistry 67
null 67
Sinthesis and characterisation of the amidine complexes trans-[PtCl(NH3)(HN=C(NH2)R)2]Cl (R= Me,Ph,CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 66
null 66
Platinum Amides from Platinum Nitriles: X-ray Crystal Structures of the Unbridged Dinuclear Compounds Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)dichloro-platinum(II)] and Bis[bis(1-imino-1-hydroxy-2,2-dimethylpropane)(1-amino-1-oxo-2,2-dimethylpropane)dichloro-platinum(II)] 65
X-ray Structure of the first Platinum Complexes with Z Configuration of the Iminoether Ligands: trans Dichlorobis(1-imino-1-methoxy- 2,2'-dimethylpropane)platinum(II) and trans-Tetrachlorobis(1-imino-1-methoxy-2,2'-dimethylpropane)platinum(IV) 63
A new generation of platinum anticancer complexes with trans geometry 62
Isomerism of amides coordinated to platinum - X-ray crystal structure of O-bonded acetamide in a platinum(II) complex 60
Isomerization of Platinum-Coordinated Iminoethers Induced by Spectator Ligands: Stabilization of the Z anti Configuration 60
null 58
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 58
Two polymorphs of potassium trichloro[diethyl (methylsulfinylmethyl)phosphonate-kS]platinum(II) with Z' = 1 and 3 in the space group P212121 55
null 55
Synthesis and Crystal Structure of the First Trinuclear Chloride-bridged Platinum(II) Complex with Mutually Perpendicular Co-ordination Planes: cyclo-Tri-mu-chloro-tris[chloro(1-hydroxy-1-imino-2,2-dimethylpropane)platinum(II)]-Dichloromethane (0.5/1) 55
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 55
MECHANISTIC AND STEREOCHEMICAL INVESTIGATION OF IMINO ETHERS FORMED BY ALCOHOLYSIS OF COORDINATED NITRILES - X-RAY CRYSTAL-STRUCTURES OF CIS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) AND TRANS-BIS(1-IMINO-1-METHOXYETHANE)DICHLOROPLATINUM(II) 53
Nucleophilic Attack of Amine and Hydroxide to Platinum Dibenzonitrile Dichloride. Crystal structure of [Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl(NHCOPh)] (2) and cis-[Pt(NH=CPhN-t-BuCH2CH2NH-t-Bu)Cl2(NCPh)](3) 53
null 52
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 51
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 49
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 48
SYNTHESIS, MUTAGENICITY, BINDING TO PBR-322 DNA AND ANTITUMOR-ACTIVITY OF PLATINUM(II) COMPLEXES WITH ETHAMBUTOL 48
Four- versus Five-coordination in Palladium(II) and Platinum(II) Complexes Containing 2,9-Dimethyl-1,10-phenanthroline (dmphen). Crystal Structures of [PtCl2(dmphen)] and [Pt(h2-C2H4)Cl2(dmphen)] 47
Synthesis and X-Ray Characterization of Two Unbridged Diplatinum(III) Compounds: cis and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 45
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 44
Stereochemically Controlled Ligands Influence Atropisomerization of Pt(II) Nucleotide Complexes. Evidence for Head-to-Head and Stable a Head-to-Tail Atropisomers 44
Viewing early stages of guanine nucleotide attach on Pt(II) complexes designed with in-plane bulk to trap initial adducts. Relevance to cis-Type Pt(II) anticancer drugs 43
New platinum antitumor complexes with chiral diamines 41
New concepts relevant to cisplatin anticancer activity from unique spectral features providing evidence that adjacent guanines in d(GpG), intrastrand-cross-linked at N7 by a cis-platinum(II) moiety, can adopt a head-to-tail arrangement 38
Kinetic study of the reaction between an antitumor 15N labeled trans- platinum iminoether complex and GMP by [1H,15N] HMQC NMR 38
Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle 35
Replacement of a NH3 by an iminoether in transplatin makes an antitumor drug from an inactive compound 34
Totale 8.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021563 0 0 0 0 0 44 52 54 95 153 123 42
2021/2022675 13 95 5 31 34 39 28 42 58 61 135 134
2022/20231.209 197 101 79 112 170 166 6 148 179 14 19 18
2023/2024399 31 63 10 33 38 144 2 14 7 4 1 52
2024/20251.296 48 31 125 32 20 78 115 87 59 66 182 453
2025/20261.338 364 140 139 282 279 134 0 0 0 0 0 0
Totale 8.602